Copyright © 2011 Gerard F. Hoyne. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. C. C. Goodnow, J. Sprent, ST. G. B. F. De, and C. G. Vinuesa, “Cellular and genetic mechanisms of self tolerance and autoimmunity,” Nature, vol. 435, no. 7042, pp. 590–597, 2005. View at Publisher · View at Google Scholar · View at Scopus
2. H. Von Boehmer and F. Melchers, “Checkpoints in lymphocyte development and autoimmune disease,” Nature Immunology, vol. 11, no. 1, pp. 14–20, 2010. View at Publisher · View at Google Scholar · View at Scopus
3. D. Mathis and C. Benoist, “Back to central tolerance,” Immunity, vol. 20, no. 5, pp. 509–516, 2004. View at Publisher · View at Google Scholar · View at Scopus
4. S. Sakaguchi, “Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self,” Nature Immunology, vol. 6, no. 4, pp. 345–352, 2005. View at Publisher · View at Google Scholar · View at Scopus
5. R. H. Schwartz, “T cell anergy,” Annual Review of Immunology, vol. 21, pp. 305–334, 2003. View at Publisher · View at Google Scholar · View at Scopus
6. D. Mathis, L. Vence, and C. Benoist, “β-cell death during progression to diabetes,” Nature, vol. 414, no. 6865, pp. 792–798, 2001. View at Publisher · View at Google Scholar · View at Scopus
7. J. Sprent, J. H. Cho, O. Boyman, and C. D. Surh, “T cell homeostasis,” Immunology and Cell Biology, vol. 86, no. 4, pp. 312–319, 2008. View at Publisher · View at Google Scholar · View at Scopus
8. S. M. Kang, A. C. Tran, M. Grilli, and M. J. Lenardo, “NF-(κ)B subunit regulation in nontransformed CD4 T lymphocytes,” Science, vol. 256, no. 5062, pp. 1452–1455, 1992. View at Scopus
9. D. Tzachanis, G. J. Freeman, N. Hirano et al., “Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells,” Nature Immunology, vol. 2, no. 12, pp. 1174–1182, 2001. View at Publisher · View at Google Scholar · View at Scopus
10. J. Wang, S. Lee, C. E. Y. Teh, K. Bunting, L. Ma, and M. F. Shannon, “The transcription repressor, ZEB1, cooperates with CtBP2 and HDAC1 to suppress IL-2 gene activation in T cells,” International Immunology, vol. 21, no. 3, pp. 227–235, 2009. View at Publisher · View at Google Scholar · View at Scopus
11. S. Grundström, P. Anderson, P. Scheipers, and A. Sundstedt, “Bcl-3 and NFkappaB p50-p50 homodimers act as transcriptional repressors in tolerant CD4+ T cells,” Journal of Biological Chemistry, vol. 279, no. 9, pp. 8460–8468, 2004. View at Publisher · View at Google Scholar · View at Scopus
12. G. A. Martins, L. Cimmino, J. Liao, E. Magnusdottir, and K. Calame, “Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell proliferation and survival,” Journal of Experimental Medicine, vol. 205, no. 9, pp. 1959–1965, 2008. View at Publisher · View at Google Scholar · View at Scopus
13. A. H. Sharpe, “Mechanisms of costimulation,” Immunological Reviews, vol. 229, no. 1, pp. 5–11, 2009. View at Publisher · View at Google Scholar · View at Scopus
14. T. R. Malek and I. Castro, “Interleukin-2 receptor signaling: at the interface between tolerance and immunity,” Immunity, vol. 33, no. 2, pp. 153–165, 2010. View at Publisher · View at Google Scholar
15. A. D. Wells, “New insights into the molecular basis of T cell anergy: anergy factors, avoidance sensors, and epigenetic imprinting,” Journal of Immunology, vol. 182, no. 12, pp. 7331–7341, 2009. View at Publisher · View at Google Scholar · View at Scopus
16. J. R. Lamb and M. Feldmann, “Essential requirement for major histocompatibility complex recognition in T-cell tolerance induction,” Nature, vol. 308, no. 5954, pp. 72–74, 1984. View at Scopus
17. V. Heissmeyer, F. Macián, S. H. Im et al., “Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins,” Nature Immunology, vol. 5, no. 3, pp. 255–265, 2004. View at Publisher · View at Google Scholar · View at Scopus
18. F. Macián, F. García-Cózar, S. H. Im, H. F. Horton, M. C. Byrne, and A. Rao, “Transcriptional mechanisms underlying lymphocyte tolerance,” Cell, vol. 109, no. 6, pp. 719–731, 2002. View at Publisher · View at Google Scholar · View at Scopus
19. E. R. Kearney, K. A. Pape, D. Y. Loh, and M. K. Jenkins, “Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo,” Immunity, vol. 1, no. 4, pp. 327–339, 1994. View at Scopus
20. G. F. Hoyne, R. E. O'Hehir, D. C. Wraith, W. R. Thomas, and J. R. Lamb, “Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice,” Journal of Experimental Medicine, vol. 178, no. 5, pp. 1783–1788, 1993. View at Publisher · View at Google Scholar · View at Scopus
21. B. Metzler and D. C. Wraith, “Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity,” International Immunology, vol. 5, no. 9, pp. 1159–1165, 1993. View at Scopus
22. Y. Chen, V. K. Kuchroo, J. Inobe, D. A. Hafler, and H. L. Weiner, “Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis,” Science, vol. 265, no. 5176, pp. 1237–1240, 1994. View at Scopus
23. P. Garside, M. Steel, F. Y. Liew, and A. M. Mowat, “CD4 but not CD8 T cells are required for the induction of oral tolerance,” International Immunology, vol. 7, no. 3, pp. 501–504, 1995. View at Scopus
24. S. Bandyopadhyay, M. Duré, M. Paroder, N. Soto-Nieves, I. Puga, and F. Macián, “Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells,” Blood, vol. 109, no. 7, pp. 2878–2886, 2007. View at Publisher · View at Google Scholar · View at Scopus
25. J. E. Harris, K. D. Bishop, N. E. Phillips et al., “Early growth response gene-2, a zinc-finger transcription factor, is required for full induction of clonal anergy in CD4+ T cells,” Journal of Immunology, vol. 173, no. 12, pp. 7331–7338, 2004. View at Scopus
26. C. G. King, J. L. Buckler, T. Kobayashi et al., “Cutting edge: requirement for TRAF6 in the induction of T cell anergy,” Journal of Immunology, vol. 180, no. 1, pp. 34–38, 2008. View at Scopus
27. I. Puga, A. Rao, and F. Macian, “Targeted cleavage of signaling proteins by caspase 3 inhibits T cell receptor signaling in anergic T cells,” Immunity, vol. 29, no. 2, pp. 193–204, 2008. View at Publisher · View at Google Scholar · View at Scopus
28. M. Safford, S. Collins, M. A. Lutz et al., “Egr-2 and Egr-3 are negative regulators of T cell activation,” Nature Immunology, vol. 6, no. 5, pp. 472–480, 2005. View at Publisher · View at Google Scholar · View at Scopus
29. R. M. Thomas, N. Chunder, C. Chen, S. E. Umetsu, S. Winandy, and A. D. Wells, “Ikaros enforces the costimulatory requirement for IL2 gene expression and is required for anergy induction in CD4+ T lymphocytes,” Journal of Immunology, vol. 179, no. 11, pp. 7305–7315, 2007. View at Scopus
30. P. E. Fields, T. F. Gajewski, and F. W. Fitch, “Blocked Ras activation in anergic CD4+ T cells,” Science, vol. 271, no. 5253, pp. 1276–1278, 1996. View at Scopus
31. S. M. Kang, B. Beverly, A. C. Tran, K. Brorson, R. H. Schwartz, and M. J. Lenardo, “Transactivation by AP-1 is a molecular target of T cell clonal anergy,” Science, vol. 257, no. 5073, pp. 1134–1138, 1992. View at Scopus
32. Y. Zha, R. Marks, A. W. Ho et al., “T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-α,” Nature Immunology, vol. 7, no. 11, pp. 1166–1173, 2006. View at Publisher · View at Google Scholar · View at Scopus
33. B. A. Olenchock, R. Guo, J. H. Carpenter et al., “Disruption of diacylglycerol metabolism impairs the induction of T cell anergy,” Nature Immunology, vol. 7, no. 11, pp. 1174–1181, 2006. View at Publisher · View at Google Scholar · View at Scopus
34. A. E. Lin and T. W. Mak, “The role of E3 ligases in autoimmunity and the regulation of autoreactive T cells,” Current Opinion in Immunology, vol. 19, no. 6, pp. 665–673, 2007. View at Publisher · View at Google Scholar · View at Scopus
35. D. L. Mueller, “E3 ubiquitin ligases as T cell anergy factors,” Nature Immunology, vol. 5, no. 9, pp. 883–890, 2004. View at Publisher · View at Google Scholar · View at Scopus
36. C. A. Ross and C. M. Pickart, “The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases,” Trends in Cell Biology, vol. 14, no. 12, pp. 703–711, 2004. View at Publisher · View at Google Scholar · View at Scopus
37. Y. A. Lam, C. M. Pickart, A. Alban et al., “Inhibition of the ubiquitin-proteasome system in Alzheimer's disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 18, pp. 9902–9906, 2000. View at Scopus
38. M. S. Jeon, A. Atfield, K. Venuprasad et al., “Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction,” Immunity, vol. 21, no. 2, pp. 167–177, 2004. View at Publisher · View at Google Scholar · View at Scopus
39. N. Yokoi, K. Komeda, HE. Y. Wang et al., “Cblb is a major susceptibility gene for rat type 1 diabetes mellitus,” Nature Genetics, vol. 31, no. 4, pp. 391–394, 2002. View at Publisher · View at Google Scholar · View at Scopus
40. M. S. Anderson, E. S. Venanzi, Z. Chen, S. P. Berzins, C. Benoist, and D. Mathis, “The cellular mechanism of Aire control of T cell tolerance,” Immunity, vol. 23, no. 2, pp. 227–239, 2005. View at Publisher · View at Google Scholar · View at Scopus
41. A. Liston, D. H. D. Gray, S. Lesage et al., “Gene dosage-limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity,” Journal of Experimental Medicine, vol. 200, no. 8, pp. 1015–1026, 2004. View at Publisher · View at Google Scholar · View at Scopus
42. A. Liston, S. Lesage, J. Wilson, L. Peltonen, and C. C. Goodnow, “Aire regulates negative selection of organ-specific T cells,” Nature Immunology, vol. 4, no. 4, pp. 350–354, 2003. View at Publisher · View at Google Scholar · View at Scopus
43. J. Aaltonen, P. Björses, J. Perheentupa et al., “An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains,” Nature Genetics, vol. 17, no. 4, pp. 399–403, 1997. View at Scopus
44. C. E. Teh, S. R. Daley, A. Enders, and C. C. Goodnow, “T-cell regulation by casitas B-lineage lymphoma (Cblb) is a critical failsafe against autoimmune disease due to autoimmune regulator (Aire) deficiency,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 33, pp. 14709–14714, 2010. View at Publisher · View at Google Scholar
45. G. F. Hoyne, E. Flening, M. Yabas et al., “Visualizing the role of Cbl-b in control of islet-reactive CD4 T cells and susceptibility to type 1 diabetes,” Journal of Immunology, vol. 186, no. 4, pp. 2024–2032, 2011. View at Publisher · View at Google Scholar
46. K. Venuprasad, C. Elly, M. Gao et al., “Convergence of itch-induced ubiquitination with MEKK1-JNK signaling in Th2 tolerance and airway inflammation,” Journal of Clinical Investigation, vol. 116, no. 4, pp. 1117–1126, 2006. View at Publisher · View at Google Scholar · View at Scopus
47. W. L. Perry, C. M. Hustad, D. A. Swing, T. Norene O'Sullivan, N. A. Jenkins, and N. G. Copeland, “The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a(18H) mice,” Nature Genetics, vol. 18, no. 2, pp. 143–146, 1998. View at Publisher · View at Google Scholar · View at Scopus
48. D. Fang, C. Elly, B. Gao et al., “Dysregulation of T lymphocyte function in itchy mice: a role for Itch in T2 differentiation,” Nature Immunology, vol. 3, no. 3, pp. 281–287, 2002. View at Publisher · View at Google Scholar · View at Scopus
49. E. Scharschmidt, E. Wegener, V. Heissmeyer, A. Rao, and D. Krappmann, “Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling,” Molecular and Cellular Biology, vol. 24, no. 9, pp. 3860–3873, 2004. View at Publisher · View at Google Scholar · View at Scopus
50. M. Gao, T. Labuda, Y. Xia et al., “Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase itch,” Science, vol. 306, no. 5694, pp. 271–275, 2004. View at Publisher · View at Google Scholar · View at Scopus
51. B. Yang, D. L. Gay, M. K. L. MacLeod et al., “Nedd4 augments the adaptive immune response by promoting ubiquitin-mediated degradation of Cbl-b in activated T cells,” Nature Immunology, vol. 9, no. 12, pp. 1356–1363, 2008. View at Publisher · View at Google Scholar · View at Scopus
52. K. F. Harvey, L. M. Shearwin-Whyatt, A. Fotia, R. G. Parton, and S. Kumar, “N4WBP5, a potential target for ubiquitination by the Nedd4 family of proteins, is a novel Golgi-associated protein,” Journal of Biological Chemistry, vol. 277, no. 11, pp. 9307–9317, 2002. View at Publisher · View at Google Scholar · View at Scopus
53. C. N. Jolliffe, K. F. Harvey, B. P. Haines, G. Parasivam, and S. Kumar, “Identification of multiple proteins expressed in murine embryos as binding partners for the WW domains of the ubiquitin-protein ligase Nedd4,” Biochemical Journal, vol. 351, no. 3, pp. 557–565, 2000. View at Publisher · View at Google Scholar · View at Scopus
54. P. M. Oliver, X. Cao, G. S. Worthen et al., “Ndfip1 protein promotes the function of itch ubiquitin ligase to prevent T cell activation and T helper 2 cell-mediated inflammation,” Immunity, vol. 25, no. 6, pp. 929–940, 2006. View at Publisher · View at Google Scholar · View at Scopus
55. N. Anandasabapathy, G. S. Ford, D. Bloom et al., “GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells,” Immunity, vol. 18, no. 4, pp. 535–547, 2003. View at Publisher · View at Google Scholar · View at Scopus
56. L. Su, N. Lineberry, Y. Huh, L. Soares, and C. G. Fathman, “A novel E3 ubiquitin ligase substrate screen identifies Rho guanine dissociation inhibitor as a substrate of gene related to anergy in lymphocytes,” Journal of Immunology, vol. 177, no. 11, pp. 7559–7566, 2006. View at Scopus
57. R. I. Nurieva, S. Zheng, W. Jin et al., “The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation,” Immunity, vol. 32, no. 5, pp. 670–680, 2010. View at Publisher · View at Google Scholar · View at Scopus
58. E. Chiffoleau, T. Kobayashi, M. C. Walsh et al., “TNF receptor-associated factor 6 deficiency during hemopoiesis induces Th2-polarized inflammatory disease,” Journal of Immunology, vol. 171, no. 11, pp. 5751–5759, 2003. View at Scopus
59. C. G. Vinuesa, M. C. Cook, C. Angelucci et al., “A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity,” Nature, vol. 435, no. 7041, pp. 452–458, 2005. View at Publisher · View at Google Scholar · View at Scopus
60. M. A. Linterman, R. J. Rigby, R. Wong et al., “Roquin differentiates the specialized functions of duplicated T cell costimulatory receptor genes CD28 and ICOS,” Immunity, vol. 30, no. 2, pp. 228–241, 2009. View at Publisher · View at Google Scholar · View at Scopus
61. D. Yu, A. H. M. Tan, X. Hu et al., “Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA,” Nature, vol. 450, no. 7167, pp. 299–303, 2007. View at Publisher · View at Google Scholar · View at Scopus
62. S. Akkaraju, W. Y. Ho, D. Leong, K. Canaan, M. M. Davis, and C. C. Goodnow, “A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis,” Immunity, vol. 7, no. 2, pp. 255–271, 1997. View at Publisher · View at Google Scholar · View at Scopus
63. C. L. Bennett, M. E. Brunkow, F. Ramsdell et al., “A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome,” Immunogenetics, vol. 53, no. 6, pp. 435–439, 2001. View at Publisher · View at Google Scholar · View at Scopus
64. C. L. Bennett, J. Christie, F. Ramsdell et al., “The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3,” Nature Genetics, vol. 27, no. 1, pp. 20–21, 2001. View at Publisher · View at Google Scholar · View at Scopus
65. M. E. Brunkow, E. W. Jeffery, K. A. Hjerrild et al., “Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse,” Nature Genetics, vol. 27, no. 1, pp. 68–73, 2001. View at Publisher · View at Google Scholar · View at Scopus
66. Y. J. Chiang, H. K. Kole, K. Brown et al., “Cbl-b regulates the CD28 dependence of T-cell activation,” Nature, vol. 403, no. 6766, pp. 216–220, 2000. View at Publisher · View at Google Scholar · View at Scopus
67. J. D. Fontenot, M. A. Gavin, and A. Y. Rudensky, “Foxp3 programs the development and function of CD4+CD25+ regulatory T cells,” Nature Immunology, vol. 4, no. 4, pp. 330–336, 2003. View at Publisher · View at Google Scholar · View at Scopus
68. S. Hori, T. Nomura, and S. Sakaguchi, “Control of regulatory T cell development by the transcription factor Foxp3,” Science, vol. 299, no. 5609, pp. 1057–1061, 2003. View at Publisher · View at Google Scholar · View at Scopus
69. C. Chen, E. A. Rowell, R. M. Thomas, W. W. Hancock, and A. D. Wells, “Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation,” Journal of Biological Chemistry, vol. 281, no. 48, pp. 36828–36834, 2006. View at Publisher · View at Google Scholar · View at Scopus
70. W. Chen, W. Jin, N. Hardegen et al., “Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3,” Journal of Experimental Medicine, vol. 198, no. 12, pp. 1875–1886, 2003. View at Publisher · View at Google Scholar · View at Scopus
71. M. C. Fantini, C. Becker, G. Monteleone, F. Pallone, P. R. Galle, and M. F. Neurath, “Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7,” Journal of Immunology, vol. 172, no. 9, pp. 5149–5153, 2004. View at Scopus
72. M. O. Li, S. Sanjabi, and R. Flavell, “Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms,” Immunity, vol. 25, no. 3, pp. 455–471, 2006. View at Publisher · View at Google Scholar · View at Scopus
73. Y. Y. Wan and R. A. Flavell, “Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 14, pp. 5126–5131, 2005. View at Publisher · View at Google Scholar · View at Scopus
74. A. B. Kulkarni, C. G. Huh, D. Becker et al., “Transforming growth factor β null mutation in mice causes excessive inflammatory response and early death,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 2, pp. 770–774, 1993. View at Publisher · View at Google Scholar · View at Scopus
75. J. C. Marie, J. J. Letterio, M. Gavin, and A. Y. Rudensky, “TGF-β1 maintains suppressor function and Foxp3 expression in CD4+ CD25+ regulatory T cells,” Journal of Experimental Medicine, vol. 201, no. 7, pp. 1061–1067, 2005. View at Publisher · View at Google Scholar · View at Scopus
76. M. M. Shull, I. Ormsby, A. B. Kier et al., “Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease,” Nature, vol. 359, no. 6397, pp. 693–699, 1992. View at Publisher · View at Google Scholar · View at Scopus
77. Y. Liu, P. Zhang, J. Li, A. B. Kulkarni, S. Perruche, and W. Chen, “A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells,” Nature Immunology, vol. 9, no. 6, pp. 632–640, 2008. View at Publisher · View at Google Scholar · View at Scopus
78. D. R. Littman and A. Y. Rudensky, “Th17 and regulatory T cells in mediating and restraining inflammation,” Cell, vol. 140, no. 6, pp. 845–858, 2010. View at Publisher · View at Google Scholar · View at Scopus
79. S. Haxhinasto, D. Mathis, and C. Benoist, “The AKT-mTOR axis regulates de novo differentiation of CD4+ Foxp3+ cells,” Journal of Experimental Medicine, vol. 205, no. 3, pp. 565–574, 2008. View at Publisher · View at Google Scholar · View at Scopus
80. J. Massague, “How cells read TGF-β signals,” Nature Reviews Molecular Cell Biology, vol. 1, no. 3, pp. 169–178, 2000. View at Scopus
81. J. Massague, J. Seoane, and D. Wotton, “Smad transcription factors,” Genes and Development, vol. 19, no. 23, pp. 2783–2810, 2005. View at Publisher · View at Google Scholar · View at Scopus
82. Y. Tone, K. Furuuchi, Y. Kojima, M. L. Tykocinski, M. I. Greene, and M. Tone, “Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer,” Nature Immunology, vol. 9, no. 2, pp. 194–202, 2008. View at Publisher · View at Google Scholar · View at Scopus
83. Y. Harada, Y. Harada, C. Elly et al., “Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells,” Journal of Experimental Medicine, vol. 207, no. 7, pp. 1381–1391, 2010. View at Publisher · View at Google Scholar · View at Scopus
84. K. Venuprasad, H. Huang, Y. Harada et al., “The E3 ubiquitin ligase Itch regulates expression of transcription factor Foxp3 and airway inflammation by enhancing the function of transcription factor TIEG1,” Nature Immunology, vol. 9, no. 3, pp. 245–253, 2008. View at Publisher · View at Google Scholar · View at Scopus
85. G. M. Delgoffe and J. D. Powell, “MTOR: taking cues from the immune microenvironment,” Immunology, vol. 127, no. 4, pp. 459–465, 2009. View at Publisher · View at Google Scholar · View at Scopus
86. R. G. Jones and C. B. Thompson, “Revving the engine: signal transduction fuels T cell activation,” Immunity, vol. 27, no. 2, pp. 173–178, 2007. View at Publisher · View at Google Scholar · View at Scopus
87. J. D. Powell and G. M. Delgoffe, “The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism,” Immunity, vol. 33, no. 3, pp. 301–311, 2010. View at Publisher · View at Google Scholar
88. D. M. Sabatini, “mTOR and cancer: insights into a complex relationship,” Nature Reviews Cancer, vol. 6, no. 9, pp. 729–734, 2006. View at Publisher · View at Google Scholar · View at Scopus
89. G. M. Delgoffe, T. P. Kole, Y. Zheng et al., “The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment,” Immunity, vol. 30, no. 6, pp. 832–844, 2009. View at Publisher · View at Google Scholar · View at Scopus
90. K. Araki, A. P. Turner, V. O. Shaffer et al., “mTOR regulates memory CD8 T-cell differentiation,” Nature, vol. 460, no. 7251, pp. 108–112, 2009. View at Publisher · View at Google Scholar · View at Scopus
91. R. R. Rao, Q. Li, K. Odunsi, and P. A. Shrikant, “The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin,” Immunity, vol. 32, no. 1, pp. 67–78, 2010. View at Publisher · View at Google Scholar · View at Scopus
92. L. V. Sinclair, D. Finlay, C. Feijoo et al., “Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking,” Nature Immunology, vol. 9, no. 5, pp. 513–521, 2008. View at Publisher · View at Google Scholar · View at Scopus
93. J. D. Powell, C. G. Lerner, and R. H. Schwartz, “Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation,” Journal of Immunology, vol. 162, no. 5, pp. 2775–2784, 1999. View at Scopus
94. S. Sauer, L. Bruno, A. Hertweck et al., “T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 22, pp. 7797–7802, 2008. View at Publisher · View at Google Scholar · View at Scopus
95. E. A. Wohlfert, L. Gorelik, R. Mittler, R. A. Flavell, and R. B. Clark, “Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-β sensitivity in vitro and in vivo,” Journal of Immunology, vol. 176, no. 3, pp. 1316–1320, 2006. View at Scopus
96. W. Ouyang, O. Beckett, Q. Ma, J. H. Paik, R. A. Depinho, and M. O. Li, “Foxo proteins cooperatively control the differentiation of Foxp3 regulatory T cells,” Nature Immunology, vol. 11, no. 7, pp. 618–627, 2010. View at Publisher · View at Google Scholar · View at Scopus